Controlling insulin production with a smartwatch
D-BSSE researchers around Martin Fussenegger have developed a gene switch that can be operated with the green LED light emitted by commercial smartwatches. This revolutionary approach could be used to treat diabetes in the future.
Find original ETH news article by Peter Rüegg.
Find original article published by Nature Communications: Mansouri M, Hussherr M-D, Strittmatter T, Buchmann P, Xue S, Camenisch G, Fussenegger M (2021) external pageSmart-watch-programmed green-light-operated percutaneous control of therapeutic transgenescall_made. Nature Communications, 7 June 2021; doi: 10.1038/s41467-021-23572-4
Learn about the Biotechnology and Bioengineering group led by Martin Fussenegger.